Abstract

LOPEZ-ARCE-ANGELES, Gustavo et al. Post-Endoscopic Retrograde Colangiopancreatography Pancreatitis. Endoscopia [online]. 2022, vol.34, n.3, pp.86-93.  Epub May 08, 2023. ISSN 2444-6483.  https://doi.org/10.24875/end.22000043.

Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis is the most common and serious complication of ERCP, its incidence varies from 8-15%; diagnosis is established with abdominal pain and elevated pancreatic enzymes (> 3 times upper limit value) the next 24 hours posterior to ERCP. There are some risk factors associated to patient (female gender, young age, previous post-ERCP pancreatitis, suspected of Oddi dysfunction) and risk factors related to procedure (difficult bile duct cannulation, ampullectomy, main pancreatic duct opacification, multiple attempts of cannulation, sphincteroplasty). Methods proven to reduce post-ERCP pancreatitis are pharmacological (rectal non-steroidal anti-inflammatory drugs) and non-pharmacological (Ringer lactate hyperhydration, early precut, pancreatic stent). It is very important to evaluate risk factors in order to apply necessary measures to reduce the incidence.

Keywords : Pancreatitis; Cholangiography; Rectal indomethacin; Pancreatic stent.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )